Cancer Treatment Denied in Indiana: Guide

Indiana cancer patients have access to world-class care at Indiana University Simon Comprehensive Cancer Center in Indianapolis, but access to insurance coverage for cutting-edge treatments is another matter. When Indiana insurers deny immunotherapy, proton therapy, genetic testing, or clinical trial participation, state and federal law provides a clear path to fight back. This guide explains Indiana's insurance landscape and your rights as a cancer patient.

Indiana's Insurance Landscape

Major insurers in Indiana include Anthem Blue Cross and Blue Shield of Indiana, UnitedHealthcare, Aetna, Cigna, and MDwise. Indiana Medicaid expanded under the ACA through the Healthy Indiana Plan (HIP 2.0), which is administered through managed care plans including Anthem, MDwise, and CareSource Indiana. The Indiana Department of Insurance (IDOI) regulates fully insured commercial health plans.

Indiana University Simon Comprehensive Cancer Center is the state's only NCI-designated comprehensive cancer center and the primary site for clinical trial enrollment in the state. Indiana also has cancer care networks through Franciscan Health, IU Health, and Eskenazi Health.

State Protections for Cancer Patients

Clinical Trial Mandate: Indiana Code Section 27-8-14.8-4 requires fully insured health insurance plans to cover routine patient care costs for enrollees participating in qualifying cancer clinical trials. Covered routine costs include standard physician visits, laboratory tests, imaging, and supportive care services that would be covered absent the trial. ERISA self-funded employer plans are not subject to this state mandate.

External Independent Review: Complete Guide" class="auto-link">External Review Rights: Indiana law provides for external review of adverse benefit determinations after internal appeals are exhausted. Expedited external review is available for urgent cases, with a binding decision required within 72 hours. The Indiana Department of Insurance administers the external review process.

Oral Chemotherapy Parity: Indiana Code Section 27-8-14.9-1 requires health insurers to cover oral anticancer medications at the same cost-sharing level as IV chemotherapy drugs. If you are paying higher cost-sharing for an oral cancer drug than you would for infusion chemotherapy, your insurer may be in violation.

Step Therapy Protections: Indiana law requires insurers to have step therapy exception processes. Oncologists can request exceptions when the required drug is contraindicated, the patient previously failed it, or when there is no supporting evidence for the mandated treatment in the patient's specific cancer type.

Common Denial Reasons in Indiana

• Immunotherapy: PD-1 and PD-L1 inhibitors are denied for off-label indications even when IU Simon Cancer Center oncologists document peer-reviewed evidence.
• Targeted therapy: Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization requirements delay access to mutation-matched drugs by weeks, impacting outcomes for Indiana cancer patients.
• Proton therapy: Denied as "investigational" for prostate cancer, pediatric brain tumors, and head and neck cancers.
• Genetic testing: Hereditary cancer gene panels and tumor genomic profiling are denied despite standard-of-care oncology guidelines.
• HIP 2.0 denials: Healthy Indiana Plan enrollees face additional scrutiny for newer oncology treatments that require prior authorization through managed care plans.

How to Appeal a Cancer Denial in Indiana

Step 1 — Internal Appeal: File a written appeal within your plan's deadline, typically 180 days from the denial. Include your oncologist's medical necessity letter, NCCN guidelines, peer-reviewed evidence, and Indiana Code Section 27-8-14.8-4 where applicable.

Step 2 — Expedited Internal Review: Request expedited processing when your oncologist certifies urgency in writing. Insurers must respond within 72 hours.

Step 3 — External Review via IDOI: After exhausting internal appeals, request external review through the Indiana Department of Insurance. Call 1-800-622-4461 or visit in.gov/idoi. The IRO's decision is binding on the insurer.

Step 4 — Medicaid Fair Hearing: If you are on HIP 2.0 or Indiana Medicaid and your coverage appeal fails internally, request a state fair hearing through the Indiana Family and Social Services Administration (FSSA).

State and Community Resources

• IU Simon Comprehensive Cancer Center Financial Counseling: Financial navigators and social workers at IU Simon assist with insurance appeals and benefit access.
• Indiana Cancer Consortium: Statewide advocacy and patient resource network.
• American Cancer Society (ACS) Helpline: 1-800-227-2345, available 24/7 for Indiana cancer patients needing insurance guidance, transportation assistance, and local support.
• Leukemia and Lymphoma Society Indiana Chapter: Financial assistance and insurance advocacy for blood cancer patients in Indiana.

Key Laws to Cite in Your Appeal

• Indiana Code § 27-8-14.8-4 (clinical trial routine cost coverage)
• Indiana Code § 27-8-14.9-1 (oral chemotherapy parity)
• Indiana Code § 27-8-28.1-6 (external review rights)
• Women's Health and Cancer Rights Act (federal)
• ACA Section 2719 (internal and external appeals)

Fight Back With ClaimBack

ClaimBack's free AI tool drafts a professional appeal letter in minutes, tailored to your insurer and denial reason. Don't let a denial be the final word.

Fight your denial at ClaimBack →

Related Reading:

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal